UCSF Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, CA, USA.
Department of Occupational Therapy, Steinhardt School of Culture, Education, and Human Development, New York University, New York, NY, USA; Kessler Foundation, East Hanover, NJ, USA.
Ann Phys Rehabil Med. 2023 Apr;66(3):101677. doi: 10.1016/j.rehab.2022.101677. Epub 2022 Nov 30.
Cognitive impairment (CI) has been recognized as one of the core multiple sclerosis (MS) symptoms that profoundly impact lives of people with MS (PwMS). Clinical trials have begun to focus on cognition as a primary or secondary outcome, but translating improvements in cognitive testing scores to functioning in the real world is difficult. Performance-based functional assessments and virtual reality (VR) assessments, which incorporate real-world challenges, have been proposed as a way to better assess functional cognition (i.e., cognitive performance and its impact on real-life cognitive functioning of PwMS) and could address the difficulty in evaluating the impact of a treatment on real-world functioning. In this narrative review, we identify and summarize some of the promising recent research applications of performance-based functional assessments and VR tools to assess functional cognition in MS. Overall, most of the studies suggest that functional and VR assessments can detect cognitive differences between people with and without MS and between PwMS with and without CI. Furthermore, performance on some of the functional and VR assessments was associated with performance on standard cognitive assessments. However, developing any guidelines on how to implement these assessments in clinical practice is difficult because of the relatively small sample size across these studies. Performance-based functional and VR assessments represent an innovative approach to increasing sensitivity of how cognitive impairments/abilities present in the daily life of PwMS. More studies, with a larger sample size, robust research methods, and pre- and post-treatment assessments, are warranted to validate relevant, accessible functional and VR assessments before implementing these assessment approaches in clinical practice.
认知障碍 (CI) 已被认为是多发性硬化症 (MS) 的核心症状之一,严重影响 MS 患者 (PwMS) 的生活。临床试验开始将认知作为主要或次要结局进行关注,但将认知测试评分的改善转化为现实世界中的功能是困难的。基于表现的功能评估和虚拟现实 (VR) 评估,纳入了现实世界中的挑战,已被提出作为一种更好地评估功能认知 (即认知表现及其对 PwMS 现实生活认知功能的影响) 的方法,并可以解决评估治疗对现实世界功能的影响的困难。在这篇叙述性综述中,我们确定并总结了基于表现的功能评估和 VR 工具在 MS 中评估功能认知的一些有前途的最新研究应用。总体而言,大多数研究表明,功能和 VR 评估可以检测出 MS 患者和无 MS 患者之间以及有 CI 和无 CI 的 PwMS 之间的认知差异。此外,一些功能和 VR 评估的表现与标准认知评估的表现相关。然而,由于这些研究的样本量相对较小,因此很难制定如何在临床实践中实施这些评估的指南。基于表现的功能和 VR 评估代表了一种创新方法,可以提高认知障碍/能力在 PwMS 日常生活中的敏感性。需要更多的研究,具有更大的样本量、稳健的研究方法以及治疗前后的评估,以验证相关的、可访问的功能和 VR 评估,然后再将这些评估方法应用于临床实践。